Prevention of etomidate induced myoclonus 20. Hwang JY, Kim JH, Oh AY, Do SH, Jeon YT, Han SH. A comparison of midazolam with remifentanil for the prevention of myoclonic movements following etomidate injection. J Int Med Res 2008; 36: 17-22. 21. Davis PJ, Lerman J, Suresh S, McGowan FX, Cote CJ, Landsman I, et al. A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 1997; 84: 982-9. 22. Holdcroft A, Morgan M, Whitwam JG, Lumley J. Effect of dose and premedication on induction complications with etomidate. Br J Anaesth 1976; 48: 199-205. 23. van Dijk B. Venous pain and involuntary muscular movements during and after administration of etomidate. A comparison of two Vol. 61, No. 2, August 2011 different formulations. Anaesthesist 1978; 27: 60-3. 24. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. model development. Anesthesiology 1997; 86: 10-23. 25. Benthuysen JL, Smith NT, Sanford TJ, Head N, Dec-Silver H. Physiology of alfentanil-induced rigidity. Anesthesiology 1986; 64: 440-6. 26. Mets B, James MF. Another complication of opiate-induced chest wall rigidity. S Afr Med J 1992; 81: 385-6. 27. Benthuysen JL, Kien ND, Quam DD. Intracranial pressure increases during alfentanil-induced rigidity. Anesthesiology 1988; 68: 438-40. 28. Arandia HY, Patil VU. Glottic closure following large doses of fentanyl. Anesthesiology 1987; 66: 574-5. 132 www.ekja.org